Celltrion
068270.KS
#724
Rank
โ‚น2.329 T
Marketcap
โ‚น11,367
Share price
0.05%
Change (1 day)
-5.51%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

Revenue for Celltrion (068270.KS)

Revenue in 2024 (TTM): โ‚น179.52 Billion

According to Celltrion 's latest financial reports the company's current revenue (TTM ) is โ‚น183.42 Billion. In 2023 the company made a revenue of โ‚น137.36 Billion a decrease over the revenue in the year 2022 that were of โ‚น145.10 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Celltrion from 2008 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) โ‚น179.52 B30.7%
2023 โ‚น137.36 B-5.34%
2022 โ‚น145.10 B18.39%
2021 โ‚น122.56 B5.29%
2020 โ‚น116.40 B68.31%
2019 โ‚น69.16 B10.77%
2018 โ‚น62.43 B14.94%
2017 โ‚น54.32 B37.42%
2016 โ‚น39.52 B13.59%
2015 โ‚น34.79 B22.19%
2014 โ‚น28.48 B122.72%
2013 โ‚น12.78 B-27.28%
2012 โ‚น17.58 B
2010 โ‚น7.02 B29.99%
2009 โ‚น5.40 B56.26%
2008 โ‚น3.45 B